Here are just a few editorial highlights from the DDNews Cancer Research News site and other online vehicles of DDNews magazine to get you acquainted with the website and show you the range of our coverage.
 

 
By Dr. Dragan Cicic, Actinium Pharmaceuticals Inc.
Patients with blood cancers often face poor long-term survival outcomes, but a new treatment approach could offer more effective targeting of cancer cells as well as lower toxicity.
 
By Kelsey Kaustinen, DDNews Senior Editor
If all milestones are met, the agreement could be worth up to $817 million
 
By Jeffrey Bouley, DDNews Chief Editor
Multiple Myeloma Research Foundation announces six new clinical trials in 2014, and Cellectar Biosciences announces IND for relapsed or refractory multiple myeloma drug
 
By Lloyd Dunlap, DDNews Managing Editor
Service center will allow the expansion of new immunotherapy experimental platforms to advance translational medical research and the treatment of cancers
 
DDNews Cancer Research Exclusive: Turning an eye to TERT
By Kelsey Kaustinen, DDNews Senior Editor
As part of the TCGA initiative, researchers have discovered multiple cases of missing chromosomes in chromophobe renal cell carcinoma, as well as rearrangements in the promoter region of the TERT gene
 
 
 
 
 
Clinical Genomics Center established by Lab21, ITOR
April 2012
SHARING OPTIONS:

CAMBRIDGE, U.K.—Lab21 recently launched a new Clinical Genomics Center at the Greenville Hospital System (GHS) Memorial Medical Campus in Greenville, S.C. Located in the GHS Institute for Translational Oncology Research (ITOR), the new center continues an ongoing collaboration to introduce complex biomarker analysis into routine cancer patient management. A strategic relationship with Life Technologies, whose Ion Torrent Personal Genome Machine will serve as the key launch platform technology, led to the establishment of the facility.  
 
"Bringing this leading-edge technology to the cancer clinic represents a significant breakthrough and the culmination of a seven-year journey," Dr. Joe Stephenson, medical director for ITOR, noted in a statement. "This genomics center is another major step towards fulfilling our vision to provide personalized cancer care—better enabling us to offer the right drug, at the right time, to the right patient."

Back







CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2014 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.